Given that C2 is expressed at higher levels in the liver and lungs, and C9 expression is restricted to the liver82, our finding of elevated levels of C2 and C9 proteins in the COVID-19 groups could be indicative of the unregulated activation of the complement system in these organs. This evidence concerns the gene C9 and COVID-19.